These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 11593070)

  • 21. Olanzapine for schizophrenia refractory to typical and atypical antipsychotics: an open-label, prospective trial.
    Lindenmayer JP; Volavka J; Lieberman J; Sheitman B; Citrome L; Chakos M; Czobor P; Parker B; Iskander A
    J Clin Psychopharmacol; 2001 Aug; 21(4):448-53. PubMed ID: 11476131
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of the efficacy, safety, and tolerability of divalproex sodium and olanzapine in the treatment of bipolar disorder.
    Zajecka JM; Weisler R; Sachs G; Swann AC; Wozniak P; Sommerville KW
    J Clin Psychiatry; 2002 Dec; 63(12):1148-55. PubMed ID: 12523875
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Olanzapine versus lithium in the acute treatment of bipolar mania: a double-blind, randomized, controlled trial.
    Niufan G; Tohen M; Qiuqing A; Fude Y; Pope E; McElroy H; Ming L; Gaohua W; Xinbao Z; Huichun L; Liang S
    J Affect Disord; 2008 Jan; 105(1-3):101-8. PubMed ID: 17531327
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Olanzapine: a review of its use in the treatment of bipolar I disorder.
    Bhana N; Perry CM
    CNS Drugs; 2001; 15(11):871-904. PubMed ID: 11700151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The antidepressant effects of risperidone and olanzapine in bipolar disorder.
    McIntyre RS; Mancini DA; Srinivasan J; McCann S; Konarski JZ; Kennedy SH
    Can J Clin Pharmacol; 2004; 11(2):e218-26. PubMed ID: 15520475
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term olanzapine treatment: weight change and weight-related health factors in schizophrenia.
    Kinon BJ; Basson BR; Gilmore JA; Tollefson GD
    J Clin Psychiatry; 2001 Feb; 62(2):92-100. PubMed ID: 11247108
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects on weight and outcome of long-term olanzapine-topiramate combination treatment in bipolar disorder.
    Vieta E; Sánchez-Moreno J; Goikolea JM; Colom F; Martínez-Arán A; Benabarre A; Corbella B; Torrent C; Comes M; Reinares M; Brugue E
    J Clin Psychopharmacol; 2004 Aug; 24(4):374-8. PubMed ID: 15232327
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The safety and early efficacy of oral-loaded divalproex versus standard-titration divalproex, lithium, olanzapine, and placebo in the treatment of acute mania associated with bipolar disorder.
    Hirschfeld RM; Baker JD; Wozniak P; Tracy K; Sommerville KW
    J Clin Psychiatry; 2003 Jul; 64(7):841-6. PubMed ID: 12934987
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Switching treatment-resistant patients with schizophrenia or schizoaffective disorder to olanzapine: a one-year open-label study with five-year follow-up.
    Karagianis JL; LeDrew KK; Walker DJ
    Curr Med Res Opin; 2003; 19(6):473-80. PubMed ID: 14594518
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does olanzapine have antidepressant properties? A retrospective preliminary study.
    Ghaemi SN; Cherry EL; Katzow JA; Goodwin FK
    Bipolar Disord; 2000 Sep; 2(3 Pt 1):196-9. PubMed ID: 11256687
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of olanzapine in dysphoric mania.
    Gonzalez-Pinto A; Lalaguna B; Mosquera F; Pérez de Heredia JL; Gutierrez M; Ezcurra J; Gilaberte I; Tohen M
    J Affect Disord; 2001 Oct; 66(2-3):247-53. PubMed ID: 11578678
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Switching outpatients with schizophrenia and related disorders on long-acting injectable antipsychotics to olanzapine: an open-label naturalistic pilot study.
    Labelle A; Bourget D; Boulay LJ; Ellis J; Tessier P
    J Clin Psychopharmacol; 2002 Dec; 22(6):545-53. PubMed ID: 12454553
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The safety of olanzapine compared with other antipsychotic drugs: results of an observational prospective study in patients with schizophrenia (EFESO Study). Pharmacoepidemiologic Study of Olanzapine in Schizophrenia.
    Gómez JC; Sacristán JA; Hernández J; Breier A; Ruiz Carrasco P; Antón Saiz C; Fontova Carbonell E
    J Clin Psychiatry; 2000 May; 61(5):335-43. PubMed ID: 10847307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Olanzapine in long-term treatment for bipolar disorder.
    Cipriani A; Rendell JM; Geddes J
    Cochrane Database Syst Rev; 2009 Jan; (1):CD004367. PubMed ID: 19160237
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical predictors of acute response with olanzapine in psychotic mood disorders.
    Zarate CA; Narendran R; Tohen M; Greaney JJ; Berman A; Pike S; Madrid A
    J Clin Psychiatry; 1998 Jan; 59(1):24-8. PubMed ID: 9491062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Olanzapine in the treatment of apathy in previously depressed participants maintained with selective serotonin reuptake inhibitors: an open-label, flexible-dose study.
    Marangell LB; Johnson CR; Kertz B; Zboyan HA; Martinez JM
    J Clin Psychiatry; 2002 May; 63(5):391-5. PubMed ID: 12019662
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Olanzapine in refractory schizophrenia after failure of typical or atypical antipsychotic treatment: an open-label switch study.
    Lindenmayer JP; Czobor P; Volavka J; Lieberman JA; Citrome L; Sheitman B; Chakos M; McEvoy JP
    J Clin Psychiatry; 2002 Oct; 63(10):931-5. PubMed ID: 12416603
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New treatments for bipolar disorder: the role of atypical neuroleptic agents.
    Ghaemi SN
    J Clin Psychiatry; 2000; 61 Suppl 14():33-42. PubMed ID: 11154015
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Olanzapine in treatment-refractory schizophrenia: results of an open-label study. The Spanish Group for the Study of Olanzapine in Treatment-Refractory Schizophrenia.
    Martín J; Gómez JC; García-Bernardo E; Cuesta M; Alvarez E; Gurpegui M
    J Clin Psychiatry; 1997 Nov; 58(11):479-83. PubMed ID: 9413413
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of open-label, 8-week trials of olanzapine monotherapy and topiramate augmentation of olanzapine for the treatment of pediatric bipolar disorder.
    Wozniak J; Mick E; Waxmonsky J; Kotarski M; Hantsoo L; Biederman J
    J Child Adolesc Psychopharmacol; 2009 Oct; 19(5):539-45. PubMed ID: 19877978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.